In Brief
Heterogeneous types of memory B cells are present in both humans and mice, yet it is unclear how different MBC subsets form or function in response to infection. Pepper and colleagues reveal that phenotypically and functionally distinct populations of polyclonal Plasmodiumspecific MBCs form in response to infection and somatically hypermutated, high-affinity, plastic IgM + memory B cells dominate the early memory response to malaria rechallenge.
SUMMARY
Humoral immunity consists of pre-existing antibodies expressed by long-lived plasma cells and rapidly reactive memory B cells (MBC). Recent studies of MBC development and function after protein immunization have uncovered significant MBC heterogeneity. To clarify functional roles for distinct MBC subsets during malaria infection, we generated tetramers that identify Plasmodium-specific MBCs in both humans and mice. Long-lived murine Plasmodium-specific MBCs consisted of three populations: somatically hypermutated immunoglobulin M + (IgM + ) and IgG + MBC subsets and an unmutated IgD + MBC population. Rechallenge experiments revealed that high affinity, somatically hypermutated Plasmodium-specific IgM + MBCs proliferated and gave rise to antibody-secreting cells that dominated the early secondary response to parasite rechallenge. IgM + MBCs also gave rise to T cell-dependent IgM + and IgG + B220 + CD138 + plasmablasts or T cell-independent B220 À CD138 + IgM + plasma cells. Thus, even in competition with IgG + MBCs, IgM + MBCs are rapid, plastic, early responders to a secondary Plasmodium rechallenge and should be targeted by vaccine strategies.
INTRODUCTION
Memory B cells (MBCs) induced by vaccine or infection are critical components of a protective humoral response. MBCs can persist for long periods of time and rapidly respond to subsequent infection through the production of antibody-secreting cells, formation of new germinal centers (GCs), and repopulation of the memory pool (Tarlinton and Good-Jacobson, 2013) . Classically defined MBCs express class-switched, somatically hypermutated B cell receptors (BCRs) after undergoing a GC reaction. These cells produce high-affinity antibodies within days of a secondary challenge, making them the gold standard for vaccine development. Recently, this homogeneous view of MBCs has been challenged and it is now recognized that diverse MBC subsets exist in both mice and humans (Dogan et al., 2009; Klein et al., 1997; Obukhanych and Nussenzweig, 2006; Pape et al., 2011; Seifert et al., 2015) . Given this, it is critical for vaccine development to understand how distinct MBC populations respond to infection.
Technical advances in tracking antigen-specific B cells have revealed that MBCs are heterogeneous. They have been shown to express either isotype switched or unswitched BCRs that have undergone various degrees of somatic hypermutation (Kaji et al., 2012; Pape et al., 2011; Toyama et al., 2002) . MBC subsets also exhibit varied expression of surface markers associated with T cell interactions such as CD73, CD80, and PDL2, revealing varied developmental histories and receptor ligand interactions (Anderson et al., 2007; Taylor et al., 2012b; Tomayko et al., 2010) . Importantly, these phenotypically different MBC subsets have also been associated with functional heterogeneity, although different studies have led to different conclusions. Some studies have demonstrated that unswitched MBCs preferentially enter GCs while switched MBCs preferentially form plasmablasts (Benson et al., 2009; Dogan et al., 2009; Pape et al., 2011; Seifert et al., 2015) . Other studies have shown instead that unswitched MBCs rapidly generate plasmablasts upon secondary challenge whereas switched MBCs preferentially re-enter GCs (McHeyzer-Williams et al., 2015) . These are important distinctions to consider since different infections may have different requirements for humoral protection. Furthermore, the majority of these studies depended upon adoptive transfer of individual MBC subsets and/or were performed in models of protein immunization or after in vitro rechallenge. It therefore remains unclear how endogenous MBC subsets respond in competition during a secondary infection.
B cells play a critical role in immune protection to the blood stage of Plasmodium infection. The protective role for antibody was first demonstrated via passive transfer of hyperimmune immunoglobulin from adults to parasitemic children (Cohen et al., 1961) , resulting in a dramatic decrease in blood stage parasitemia. Little is known, however, about the cellular source of Plasmodium-specific antibodies largely due to a lack of tools to analyze Plasmodium-specific B cells. We therefore generated B cell tetramers specific for the blood stage Plasmodium antigen, Merozoite Surface Protein 1 (MSP1). MSP1 is a key surface protein expressed by the parasite and is required for erythrocyte invasion (Kadekoppala and Holder, 2010) . Antibodies generated against the 19kD C terminus region of MSP1 potently inhibit erythrocyte invasion and animals actively, or passively, immunized against MSP1 are protected against subsequent infection (Blackman et al., 1990; Hirunpetcharat et al., 1997; Moss et al., 2012) . Furthermore, the acquisition of both IgG and IgM antibodies against the MSP1 C terminus have been associated with the development of clinical immunity (al-Yaman et al., 1996; Arama et al., 2015; Branch et al., 1998; Dodoo et al., 2008; Riley et al., 1992 The direct ex vivo visualization of antigen-specific B cells during infection has been difficult to accomplish due to a lack of tools and techniques to track small population of B cells. We therefore adopted techniques used to analyze MBC development in response to protein immunization to study MBC development and function in response to blood stage malaria infection in C57BL/6 mice. To accomplish this, we generated a phycoerythrin (PE)-conjugated B cell tetramer containing the majority of the 19kD C-terminal portion of the MSP1 protein from P. chabaudi (Taylor et al., 2012a) . This reagent was used with magnetic bead-based enrichment to analyze malaria-specific B cells directly ex vivo throughout all phases of the immune response.
In all experiments, splenocytes were first stained with a decoy reagent and then with the MSP1 PE tetramer to exclude cells binding other components of the tetramer (Taylor et al., 2012a) . Anti-PE coated magnetic beads were then used to enrich both decoy-specific and MSP1-specific B cells, which were subsequently stained with antibodies for analysis by multiparameter flow ctometry. Antibody panels were based upon gating strategies developed to visualize all stages of mature B2 B cell differentiation. (Taylor et al., 2012b) . While GC responses were not present at day 8, they began to emerge at day 12, and expanded to a peak of about 15,000 MSP1
À cells at day 20, at which point numerous IgD À germinal centers could also be found in the spleen by immunofluorescent microscopy ( Figures 2A and 2B , S3B, S3C). This was further confirmed by the presence of various sub-classes of MSP1-specific IgG + antibodies measured in the serum ( Figure S3D ).
To determine which of these early fates persisted into the memory phase of the response, we characterized MSP1 + B cells for approximately a year using similar gating strategies described above (Figures 2A and 2B ). Although CD138 + PBs initially waned betweens days 20 to 40, a small, consistently present CD138 + population re-emerged around day 85 suggesting that these were splenic plasma cells (PCs), similar to recent work demonstrating that PCs emerge after MBCs in response to protein immunization (Bortnick et al., 2012; Weisel et al., 2016 persisted for 340 days post infection, at the latest time points IgD + MBCs stably persisted, whereas both the IgM + and swIg + MBCs declined ( Figure 3B ). The persistence of heterogeneous MBCs after malaria infection in mice led us to ask whether switched and unswitched P. falciparum-specific MBCs also occur in exposed individuals residing in an endemic area. Although IgG + P. falciparum-specific MBCs have been detected by ELISPOT in individuals exposed to both high Weiss et al., 2010) and low (Clark et al., 2012; Ndungu et al., 2013; Wipasa et al., 2010) malaria transmission, it is unknown whether P. falciparum infection induces antigen-specific unswitched MBCs. Antigen-specific enrichment experiments were therefore performed on peripheral blood mononuclear cells (PBMCs) collected from P. falciparum-infected Malian subjects during the malaria season (Crompton et al., 2008) or malarianaive U.S. subjects. To enhance the sensitivity of Plasmodiumspecific cell detection (less than 20 million PBMC were available in some samples), we generated B cell tetramers using the C-terminal region of MSP1 and apical membrane antigen 1 (AMA1) from the human P. falciparum (3D7) strain. In Malian subjects, we found that approximately 40% of the P. falciparum-specific B cells in blood were CD21 + CD27 + MBCs in keeping with expected frequencies of total MBCs in human blood (Kaminski et al., 2012; Klein et al., 1998; Tangye and Good, 2007) (Figure S4A) . Furthermore, there was a 6-fold increase in the total number of P. falciparum-specific B cells and a 60-fold increase among CD27 + CD21 + MBCs compared to uninfected U.S. controls ( Figure S4B ). We further characterized the P. falciparumspecific CD27 + MBCs from Malian samples for their expression of BCR isotype and found that they comprised both switched and unswitched cells ( Figure S4C ). Thus, heterogeneous populations of Plasmodium-specific MBCs are expanded in both mice and humans and future studies will address similarities and differences between these populations.
Murine MSP1-Specific MBC Subsets Are Phenotypically and Genetically Distinct
To further dissect the unique phenotypic and functional characterists associated with distinct Plasmodium-specific MBCs, we performed additional studies in mice. Previous studies have demonstrated that MBC subsets display heterogeneous expression of surface markers associated with T cell interactions including CD73 and CD80 on both switched and unswitched MBCs (Anderson et al., 2007; Tomayko et al., 2010; Yates et al., 2013 B cell expression of both CD73 and CD80 is associated with expression of activation-induced cytidine deaminase (AID) and in some cases but not all, germinal center dependence (Anderson et al., 2007; Kaji et al., 2012; Taylor et al., 2012b; Weisel et al., 2016) . On the basis of these observations, we hypothesized that our CD73 + CD80 + MSP1 + IgM + MBCs might represent a previously unexplained population of somatically hypermutated, unswitched MBCs identified in other immunization models (Kaji et al., 2012; Pape et al., 2011 Figure S4 .
75% of V L chain sequences of CD73 + CD80 + IgM + cells were mutated with a mean of 3 mutations in both chains ( Figure 3D ). As expected, swIg + MBCs were also highly mutated (97%) and displayed significantly more mutations (mean of 8) in both V H and V L chains ( Figure 3D ). Because increased levels of SHM are associated with an overall increase in BCR affinity (Chan and Brink, 2012) (Kolhatkar et al., 2015) . Importantly, these studies further confirm the specificity of our MSP1-tetramer techniques as 100% of expressed clones bound MSP1 protein, whereas the control PC-specific mAb did not ( Figure 3E ). Furthermore, despite overall fewer mutations, individual BCRs from IgM + MBCs showed comparable affinity for the MSP1 protein to swIg + MBCs ( Figure 3E ).
These data therefore demonstrate that expression of CD73 and CD80 on both IgM + and swIg + MBCs is associated with increased levels of SHM, resulting in similar BCR affinities. These findings raise the question of how these MBCs might respond in competition during a secondary infection.
Secondary Infection Induces the Rapid Proliferation and Differentiation of MSP1-Specific MBCs
To understand how the MBCs described above function during a secondary infection, we rechallenged mice in the memory phase of the response with iRBCs. Of note, our experimental conditions were distinct from several previous studies that utilized adoptive transfer of individual MBC populations followed by antigen rechallenge. In intact memory mice, MBC competition for antigen and T cell help, as well as the presence of pre-existing antibodies factor into the overall response, perhaps as they would in repeatedly infected humans. (Figures 2 and 4C ). Three days after iRBC challenge, a newly formed MSP1 + B220
+ CD138 + population emerged and remained expanded at day 5, suggesting these were the product of recently activated MBCs ( Figures 4C and 4D ). The rapid formation of this population was unique to a memory response as we did not observe a significant B220 + CD138 + population form in naive mice 3 days after the same iRBC challenge ( Figure S5B ). Additional quantification of the B220 + CD138 À B cells and B220 À CD138 + PCs revealed that these populations also increased in number after rechallenge ( Figure 4D) Figure S6B , Figure 3B ). The activated precursors and MBCs were largely isotype switched ( Figure S6B ). In contrast, very few of the MSP1 + IgD + MBCs were proliferating.
These data demonstrate that IgM + MBCs rapidly respond to secondary infection and make up the majority of the early proliferating plasmablasts.
To Figures 5A and 5B ).
To confirm that our intracellular antibody staining represented measurable changes of secreted antibody in vivo, we performed MSP1-19 protein-specific ELISAs on serum samples taken from individual mice before or after challenge. In conjunction with what was observed by flow cytometry, 3 days after infection MSP1-specific IgM antibody expression was significantly increased over pre-challenge levels while IgG antibody expression remained unchanged ( Figure 5C , top row). Two days later however, on day 5, we observed significant increases in MSP1-specific IgG antibodies, while IgM antibody levels remained elevated (Figure 5C, bottom row) more dramatically than what we had observed at the higher dose challenge ( Figures 6A, 6B, and 5B). This was especially striking given the 2.5-fold numerical disadvantage of IgM + MBCs compared to swIg + MBCs 100 days post-challenge ( Figure 3B ).
Although this ruled out dose dependent effects, it was also possible that the time of rechallenge influenced our results, for example if a germinal center was ongoing, which was the case for the 12-16 week rechallenge experiments. We therefore tested whether the presence of an ongoing GC reaction at the time of challenge influenced the early secondary responders. Memory mice 35 weeks post infection, in which the GC reaction had ended and IgM + and swIg + MBCs were in equal number (Figures 2 and 3) , were therefore given a secondary challenge with 1 3 10 7 iRBCs and analyzed 3 days later. As seen in mice with an ongoing GC, IgM + cells were still the predominant early antibody-expressing population ( Figure 6C ). Together, these data suggest that despite variations in infectious dose, the presence or absence of a GC, or shifts in the numerical ratio of IgM 
IgM + MBCs Generate Both T-Independent and TDependent Antibody Secreting Effectors
The predominant secondary IgM + memory response led us to interrogate the mechanisms of the early IgM response. We hypothesized that differences in T cell dependence could perhaps allow some populations to form faster than others. To test this, mice were treated a CD4 + T cell-depleting antibody (clone GK1.5) for 2 days prior to rechallenge and formation of PBs and PCs was assessed 3 days later. Strikingly, while MSP1 + PBs did not form in the absence of T cell help, the PCs in the GK1.5 treated animals expanded comparably to those in a T cell replete rechallenged mouse (Figures 7A and 7B) . To assess the isotype of the responding T-independent ASCs, we again performed intracellular Ig staining. In mice depleted of T cells, more than 85% of the Ig + CD138 + ASCs expressed IgM + ( Figure 7C ). Therefore, the formation of both unswitched and switched PBs is T cell dependent yet predominantly IgM + expressing PCs can still form in a T cell independent manner. These data therefore suggest that IgM + MBCs can form two unique ASC populations in two mechanistically distinct ways, again highlighting their plasticity.
DISCUSSION
Here we focused on understanding how recently described MBC subsets develop and function in response to infection with a relevant pathogen. To accomplish this, we generated B cell tetramers and utilized enrichment techniques to perform analyses of endogenous Plasmodium-specific B cells in malaria-exposed humans and mice. Importantly, the results presented in these studies highlight the fact that IgM + and IgD + MBCs are unique populations of cells with distinct phenotypic, functional, and survival properties. Furthermore, these studies emphasize that IgM + MBCs are not low affinity cells that provide redundancy to IgG + MBCs. On the contrary, Plasmodium-specific IgM + MBCs express high affinity and somatically hypermutated BCRs and rapidly respond to produce antibodies prior to IgG + MBCs, even in competition. Lastly, these studies reveal that a secondary memory response results in the generation of T-dependent plasmablasts and T-independent plasma cells that create multiple layers of antibody secreting cells.
In many ways, the results presented reconcile many of the disparate findings from various studies using a variety of protein immunization strategies, BCR transgenics, and isolated transfer and rechallenge techniques. Dividing unswitched cells into two et al., 2011) or expression of markers associated with somatic hypermutation (Zuccarino-Catania et al., 2014) can predict MBC function, reconciling the findings of these two separate studies. While the IgD + MBCs were remarkably stable, both the IgM + and swIg + subsets persisted with similar, and less stable kinetics as predicted by studies demonstrating a loss of somatically hypermutated B cells over time (Gitlin et al., 2016) . IgD + MBCs might represent a durable, expanded memory population that provides a high number of pathogen-specific clones with kinetics similar to naive B cells.
We have also addressed how distinct antigen-specific MBC subsets respond to a secondary infection in vivo in competition and demonstrate a hierarchy of MBC responsiveness to secondary infection. Surprisingly, at the earliest time points, IgM + MBCs are the dominant producers of ASCs at all doses of rechallenge and time points examined. By 5 days post secondary infection, however, IgM antibody production did not continue to increase while switched PBs began to produce significant amounts of antibody highlighting that this dominance is transient. Therefore, unlike previous studies suggesting that IgM cells do not readily form PBs perhaps due to their low affinity (Pape et al., 2011) or form plasmablasts with similar kinetics to IgG + PBs (ZuccarinoCatania et al., 2014) , in this system, IgM + MBCs are high affinity, rapid, plastic early responders that appear to initate the secondary response.
Our results might explain recent data associating the depth and breadth of Plasmodium-specific IgM antibodies with resistance to infection (Arama et al., 2015 (Boyle et al., 2015) . While the importance of IgM antibodies in Plasmodium infection has been shown in murine models (Couper et al., 2005) , additional studies examining the importance of IgM antibodies in human malaria infection as well as the comparison of Plasmodium-specific IgM + MBCs found in our murine system to those we identified in malaria-exposed humans are necessary and ongoing. Finally, these studies help to clarify long-standing controversies concerning the level of T cell dependence of secondary MBC responses (Kurosaki et al., 2015) . Although many studies in humans and mice have demonstrated T cell-independent activation of MBCs (Bernasconi et al., 2002; Richard et al., 2008; Von Eschen and Rudbach, 1974) without the help of T cells (Ise et al., 2014) . Our results demonstrate that both T-dependent and T-independent processes contribute to a secondary MBC response and support recent studies demonstrating that IgM + MBCs can be reactivated in a T-independent manner when transferred in isolation into T celldepleted mice (Zuccarino-Catania et al., 2014) . Specifically, secondary IgM + and IgG + PB formation was T-dependent, while the rapid generation of non-dividing, antibody-secreting IgM + PCs was T-independent, raising many questions about the origins of these cells. It is tempting to speculate that the murine somatically hypermutated IgM + MBCs identified in these studies are homologous to human IgM + MBCs that can mediate T-independent IgM + responses to bacterial infection 
Plasmodium Infection
Plasmodium chabaudi chabaudi (AS) parasites were maintained as frozen blood stocks and passaged through donor mice. Primary mouse infections were initiated by intraperitoneal (i.p.) injection of 1 3 10 6 iRBCs from donor mice. Secondary mouse infections were performed 12-35 weeks after primary infection using a dose of 1 3 10 7 iRBCs injected intravenously (i.v.). In some cases, when indicated, secondary challenges were given at lower doses using either 1 3 10 3 or 1 3 10 5 iRBCs injected i.v.
Tetramer Production
For murine studies, recombinant His-tagged C-terminal MSP1 protein (amino acids 4960 to 5301) from P. chabaudi (AS) (provided by Dr. Jean Langhorne, Francis Crick Institute) was produced by Pichia pastoris and purified using a Ni-NTA agarose column as previously described (Ndungu et al., 2009 ). Purified P. chabaudi MSP1 protein was biotinylated and tetramerized with streptavidin-PE (Prozyme) as previously described (Taylor et al., 2012a) . For human studies, AMA1 protein from P. falciparum (3D7) (provided by Dr. Julian Rayner, Welcome Trust Sanger Institute) and MSP1-19 protein from P. falciparum (3D7) (provided by Dr. Anthony Holder, Francis Crick Institute) were biotinylated and tetramerized as described above. Decoy reagent to gate out non-MSP1 + B cells was made by conjugating SA-PE to AF647 using an AF647 protein labeling kit (ThermoFisher), washing and removing any unbound AF647, and incubating with an excess of an irrelevant biotinylated HIS-tagged protein, similar to what has been previously described (Taylor et al., 2012a) .
Mouse and Human Cell Enrichment and Flow Cytometry
For murine samples, splenic cell suspensions were prepared and resuspended in 200 ml in PBS containing 2% FBS and Fc block (2.4G2) and first incubated with Decoy tetramer at a concentration of 10 nM at room temperature for 10 min. MSP1-PE tetramer was added at a concentration of 10 nM and incubated on ice for 30 min. Cells were washed, incubated with anti-PE magnetic beads for 30 min on ice and passed over magnetized LS columns (Miltenyi Biotec) to elute the bound cells as previously described (Taylor et al., 2012a) . For human samples, PBMC were similarly stained and enriched using Decoy, PfAMA1, and PfMSP1 tetramers. All bound cells were stained with surface antibodies followed by intracellular antibody staining when needed (Table S1 ). All cells were run on the LSRII (BD) and analyzed using FlowJo software (Treestar).
Single Cell BCR Sequencing and Cloning Single MSP1 + MBCs were FACS sorted using an ARIAII into 96-well plates. BCRs were amplified and sequenced from the cDNA of single cells as previously described (Schwartz et al., 2014) , with additional IgH primers used (Tiller et al., 2009) . Amplified products were cloned and generated mAbs using previously described methods (Schwartz et al., 2014; Tiller et al., 2009 ).
ELISAs
Costar 96-well EIA/RIA plates (Fisher Scientific) were coated overnight at 4 C with 10 mg/ml of MSP1 protein. Plates were blocked with 2% BSA prior to sample incubation. For serum samples, plates were incubated with serially diluted serum from naive or infected animals. For cloned mAbs, plates were incubated with serially diluted mAbs starting at 10 ng/ml. Each sample was plated in duplicate. For serum samples, bound antibodies were detected using either IgM Biotin (II/41), IgG Biotin (Poly4053), IgG1 Biotin (A85-1), IgG2c Biotin (5.7), IgG2b Biotin (R12-3), or IgG3 (R40-82) followed by Streptavidin-HRP (BD). For mAbs, bound antibodies were detected with mouse anti-human IgG-HRP (SouthernBiotech). Absorbance was measured at 450 nm using an iMark Microplate Reader (Bio-Rad).
ELISPOT 96-well ELISPOT plates (Millipore) were coated overnight at 4 C with 10 mg/ml of Ig(H+L) unlabeled antibody (Southern Biotech). Plates were blocked with 10% FBS in complete DMEM (GIBCO). MSP1 + MBCs were sorted using a FACSAria (BD) from memory mice 2 days after rechallenge. Cells of each MBC population were plated onto coated ELISPOT plates and incubated at 37 C for an additional 2.5 days. Cells were washed off and secreted antibodies were detected using either IgM Biotin (II/41) or IgG Biotin (Poly4053) followed by Streptavidin-HRP (BD). Nonspecific (background) spots were determined in wells containing no cells. Spots were developed using AEC substrate (BD) and counted and analyzed using the CTL ELISPOT reader and Immunospot analysis software (Cellular Technology Limited). Number of spots detected per well were used to calculate spot frequency per 1 3 10 5 total cells.
Depletion of CD4+ T Cells
For depletion of CD4 + T cells, GK1.5 monoclonal antibody to CD4 (rIgG2b; BioXcell) was used. One and two days prior to secondary challenge, memory mice were given an i.p. injection of 200 mg GK1.5 or isotype control diluted in PBS. Efficiency of CD4 + T cell depletion was monitored by checking blood of mice pre-depletion, day 1 post injection and day of challenge. Depletion was found to be greater than 98% of CD4 + T cells as assessed by a non-GK1.5 competing anti-CD4 clone, RM4-4.
Statistical Analysis
Unpaired, two-tailed Student's t tests were applied to determine the statistical significance of the differences between groups with Prism (Graphpad) software. The p values were considered significant when p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
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